Page 195 - 80 guidelines for the treatment of malaria_opt

ANNEX 9. Treatment of Plasmodium vivax, P. ovale and P. malariae infections

a9.7 references

1. World Malaria Report 2008. Geneva, World Health Organization, 2008 (http://www.who.
int/malaria/wmr2008/malaria2008.pdf, accessed 27 October 2009).
2. Hay SI et al. The global distribution and population at risk of malaria: past, present, and
future. Lancet, 2004, 4:327–336.
3. Mendis K et al. The neglected burden of Plasmodium vivax malaria. American Journal of
Tropical Medicine and Hygiene, 2001, 64:97–106.
4. Tjitra E. Improving the diagnosis and treatment of malaria in Eastern Indonesia
[dissertation]. In: Menzies School of Health Research. Darwin, Australia, Northern Territory
University, 2001.
5. Lysenko AJ, Beljaev A. An analysis of the global distribution of Plasmodium ovale. Bulletin
of the World Health Organization, 1969, 40:383–394.
6. Poespoprodjo JR et al. Vivax malaria: a major cause of morbidity in early infancy. Clinical
Infectious Diseases, 2009, 48:1704–1712.
7. Genton B et al. Plasmodium vivax and mixed infections are associated with severe malaria
in children: a prospective cohort study from Papua New Guinea. PLoS Medicine, 2008,
5:e136.
8. Beg MA et al. Cerebral involvement in benign tertian malaria. American Journal of Tropical
Medicine and Hygiene, 2002, 67:230–232.
9. Mohapatra MK et al. Atypical manifestations of Plasmodium vivax malaria. Indian Journal
of Malariology, 2002, 38:18–25.
10. Udomsangpetch R et al. Rosette formation by Plasmodium vivax. Transactions of the Royal
Society of Tropical Medicine and Hygiene, 1995, 89:635–637.
11. Fried M et al. Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and
TNF-alpha associated with pregnancy outcomes. Journal of Immunology, 1998, 160:2523–
2530.
12. Nosten F et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet, 1999, 354:546–
549.
13. Tjitra E et al. Field evaluation of the ICT malaria P.f/P.v immunochromatographic test for
detection of Plasmodium falciparum and Plasmodium vivax in patients with a presumptive
clinical diagnosis of malaria in eastern Indonesia. Journal of Clinical Microbiology, 1999,
37:2412–2417.
14. Coleman RE et al. Field evaluation of the ICT Pf/Pv immunochromatographic test for the A9
detection of asymptomatic malaria in a Plasmodium falciparum/vivax endemic area in
Thailand. American Journal of Tropical Medicine and Hygiene, 2002, 66:379–383.
15. Iqbal J, Khalid N, Hira PR. Comparison of two commercial assays with expert microscopy
for confirmation of symptomatically diagnosed malaria. Journal of Clinical Microbiology,
2002, 40:4675–4678.

181